Richard Akele

Richard Akele

Auto-generated profile, based on publicly available information

Richard Akele

Department of Biomedical Science, School of Applied Science, University Of Brighton, London, United Kingdom

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
MGMahir Gachabayov
Mahir Gachabayov
Khan SharunKhan Sharun
Khan Sharun
DFDaniel M. Felsenreich
Daniel M. Felsenreich
Firzan NainuFirzan Nainu
Firzan Nainu
SASamsul Anwar
Samsul Anwar
Harapan HarapanHarapan Harapan
Harapan Harapan
Background: Risk perceptions of coronavirus disease 2019 (COVID-19) are considered important as they impact community health behaviors. The aim of this study was to determine the perceived risk of infection and death due to COVID-19 and to assess the factors associated with such risk perceptions among community members in low- and middle-income countries (LMICs) in Africa, Asia, and South America. Methods: An online cross-sectional study was conducted in 10 LMICs in Africa, Asia, and South America from February to May 2021. A questionnaire was utilized to assess the perceived risk of infection and death from COVID-19 and its plausible determinants. A logistic regression model was used to identify the factors associated with such risk perceptions. Results: A total of 1,646 responses were included in the analysis of the perceived risk of becoming infected and dying from COVID-19. Our data suggested that 36.4% of participants had a high perceived risk of COVID-19 infection, while only 22.4% had a perceived risk of dying from COVID-19. Being a woman, working in healthcare-related sectors, contracting pulmonary disease, knowing people in the immediate social environment who are or have been infected with COVID-19, as well as seeing or reading about individuals infected with COVID-19 on social media or TV were all associated with a higher perceived risk of becoming infected with COVID-19. In addition, being a woman, elderly, having heart disease and pulmonary disease, knowing people in the immediate social environment who are or have been infected with COVID-19, and seeing or reading about individuals infected with COVID-19 on social media or TV had a higher perceived risk of dying from COVID-19. Conclusions: The perceived risk of infection and death due to COVID-19 are relatively low among respondents; this suggests the need to conduct health campaigns to disseminate knowledge and information on the ongoing pandemic.

29 June 2025 in Global South Health Horizons
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
EAEsther Adejumo
Esther Adejumo
OOOsareniro Osakue
Osareniro Osakue
SESamuel EKE
Samuel EKE
RARichard Akele
Richard Akele
CEComfort Enitan
Comfort Enitan
Introduction: The integration of genomics and proteomics, two cornerstone omics technologies, has transformed our understanding of biological systems, enabling deeper insights into disease mechanisms, biomarker discovery, and the development of personalised medicine. While genomics uncovers genetic blueprints, proteomics reveals functional protein expressions, making their combined use essential for a holistic view of biological processes. This narrative review explores the current state, advantages, challenges, and prospects of integrating genomics and proteomics in biological research, particularly in the context of translational medicine and global health applications. Methods: A systematic literature search was conducted across four databases—PubMed, Scopus, Web of Science, and Google Scholar, for English-language peer-reviewed articles published between January 2015 and May 2025. A PRISMA-based approach guided article screening and selection. Inclusion criteria focused on studies addressing multi-omics integration, relevant technologies, clinical applications, and associated ethical concerns. The findings were synthesised using thematic analysis. Synthesis: The review highlights the growing synergy between genomics and proteomics in enhancing disease diagnosis, drug discovery, and precision medicine. Advances in next-generation sequencing and mass spectrometry, coupled with computational tools such as MOFA+ and AlphaFold, have improved data integration. However, challenges persist, including high data complexity, computational demands, ethical/legal concerns, and limited access in low-resource settings. Conclusion: Integrated omics approaches hold immense potential to revolutionise healthcare and biological discovery. Addressing current barriers and fostering global collaboration, particularly in underrepresented regions, are critical to realising the full benefits of genomics and proteomics integration.

22 March 2022 in F1000Research
Verified
Journal Article
Open access
MGMahir Gachabayov
Mahir Gachabayov
Khan SharunKhan Sharun
Khan Sharun
DFDaniel M. Felsenreich
Daniel M. Felsenreich
Firzan NainuFirzan Nainu
Firzan Nainu
SASamsul Anwar
Samsul Anwar
Harapan HarapanHarapan Harapan
Harapan Harapan
Background: Risk perceptions of coronavirus disease 2019 (COVID-19) are considered important as they impact community health behaviors. The aim of this study was to determine the perceived risk of infection and death due to COVID-19 and to assess the factors associated with such risk perceptions among community members in low- and middle-income countries (LMICs) in Africa, Asia, and South America. Methods: An online cross-sectional study was conducted in 10 LMICs in Africa, Asia, and South America from February to May 2021. A questionnaire was utilized to assess the perceived risk of infection and death from COVID-19 and its plausible determinants. A logistic regression model was used to identify the factors associated with such risk perceptions. Results: A total of 1,646 responses were included in the analysis of the perceived risk of becoming infected and dying from COVID-19. Our data suggested that 36.4% of participants had a high perceived risk of COVID-19 infection, while only 22.4% had a perceived risk of dying from COVID-19. Being a woman, working in healthcare-related sectors, contracting pulmonary disease, knowing people in the immediate social environment who are or have been infected with COVID-19, as well as seeing or reading about individuals infected with COVID-19 on social media or TV were all associated with a higher perceived risk of becoming infected with COVID-19. In addition, being a woman, elderly, having heart disease and pulmonary disease, knowing people in the immediate social environment who are or have been infected with COVID-19, and seeing or reading about individuals infected with COVID-19 on social media or TV had a higher perceived risk of dying from COVID-19. Conclusions: The perceived risk of infection and death due to COVID-19 are relatively low among respondents; this suggests the need to conduct health campaigns to disseminate knowledge and information on the ongoing pandemic.

28 December 2024 in Avicenna Journal of Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
RARichard Yomi Akele
Richard Yomi Akele
AOAdesuyi Ayodeji Omoare
Adesuyi Ayodeji Omoare
BDBanenat Dogonyaro
Banenat Dogonyaro
MIMichael Unata Iduh
Michael Unata Iduh
TATemitayo Oluwatomisin Ajayi
Temitayo Oluwatomisin Ajayi
Mpox, declared a Public Health Emergency of International Concern by the World Health Organization (WHO), poses a growing global threat. The resurgence, driven by the highly transmissible and severe clade Ib strain from the Democratic Republic of the Congo, raises concerns about a potential pandemic. This narrative review aims to identify actionable strategies to mitigate the current Mpox outbreak by leveraging lessons from past health crises, particularly COVID-19, and to highlight future research priorities essential for global preparedness. A comprehensive literature review from 2018 to 2024 was conducted using Google Scholar, Scopus, and PubMed databases, focusing on Mpox transmission, vaccine efficacy, antiviral treatments, and public health responses. Our findings revealed that the resurgence of Mpox is fueled by viral evolution, ecological changes, and inadequate surveillance, exacerbated by inequitable healthcare access and insufficient public health infrastructure. While existing vaccines, such as Jynneos and ACAM2000, offer protection, their long-term efficacy and safety across diverse populations require further study. Antiviral treatments, including tecovirimat and brincidofovir, show promise but lack optimized care protocols and face challenges such as emerging resistance. Lessons from the COVID-19 response underscore the importance of enhancing global surveillance systems, strengthening healthcare infrastructure, ensuring equitable vaccine distribution, and fostering community engagement. Effective Mpox management also requires standardized treatment guidelines and the integration of genomic monitoring to track viral evolution and drug resistance. Urgent international collaboration is needed to avert a potential Mpox pandemic. Priorities include advancing research on long-term vaccine efficacy, optimizing antiviral therapies, and improving care for severe cases. Actionable recommendations include robust policies, sustainable funding, and global collaboration to strengthen pandemic preparedness and mitigate Mpox’s impact.

31 March 2021 in Brazilian Dental Science
Verified
Journal Article
Open access
PDF file
BOBernard Oluwapelumi Oluboyo
Bernard Oluwapelumi Oluboyo
MCMaihankali J Charles
Maihankali J Charles
RARichard Akele
Richard Akele
FAFunmilayo Akinseye
Funmilayo Akinseye
AOAdeola Oluboyo
Adeola Oluboyo
Objetive: Manufacturers of toothpastes claim that their products are active against oral microbiome capable of causing tooth decay. The objective of this study was to investigate the manufacturers’ claim using some of the toothpaste products sold in Ado-Ekiti, Nigeria. Material and methods: The antibacterial potentials of five commercialized toothpaste products (designated sodium fluoride-zinc sulphate, benzyl alcohol-sodium fluorophosphate, sodium fluoride-eugenol, sodium fluoridesodium laurylsulfate and sodium fluoridepotassium nitrate) were tested against six oral isolates of dental caries and periodontal origin – Staphylococcus aureus, Streptococcus mitis, Streptococcus salivarius, Streptococcus pyogenes and Pseudomonas aeruginosa. The antimicrobial potentials were evaluated using modified agar well diffusion method. Various dilutions of the toothpaste products from 1:1 to 1:16 were tested against each test microorganism. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the toothpastes were determined. Results: sodium fluoride-zinc sulphate, benzyl alcoholsodium fluorophosphate and sodium fluorideeugenol toothpastes showed inhibitory effects on S. aureus, S. mitis and S. salivarius. Sodium fluoride-sodium laurylsulfate and sodium fluoride-potassium nitrate toothpastes showed no inhibitory effect on the organisms except S. pyogenes. Only sodium fluoride-potassium nitrate toothpaste inhibited E. coli while none of the toothpastes inhibited P. aeruginosa. The MIC and MBC of sodium fluoride-zinc sulphate, benzyl alcohol-sodium fluorophosphate, and sodium fluoride-eugenol toothpastes showed bacteriostatic and bactericidal effects on the organisms. Sodium fluoride-zinc sulphate, benzyl alcohol-sodium fluorophosphate, and sodium fluoride-eugenol toothpastes showed comparable effects on S. aureus, S. mitis and S. salivarius. Sodium fluoride-eugenol toothpaste was strongest against S. mitis, benzyl alcoholsodium fluorophosphates toothpaste was strongest against S. pyogenes, sodium fluoridezinc sulphate toothpaste was strongest against S. salivarius and only sodium fluoride-potassium nitrate toothpaste inhibited E. coli. Conclusion: The manufacturer’s claim is upheld by this study for sodium fluoride-zinc sulphate, benzyl alcohol-sodium fluorophosphate and sodium fluoride-eugenol toothpastes. However, sodium fluoride-sodium laurylsulfate and sodium fluoride-potassium nitrate toothpastes showed limited inhibitory potentials. Keywords Antibacterial; Caries; Oral isolates; Periodontitis; Toothpastes.

1 January 2024 in Narra J
Verified
Journal Article
Open access
PDF file
WUWina S. Utama
Wina S. Utama
WLWahyu Lestari
Wahyu Lestari
SHSitti Hajar
Sitti Hajar
MSMahriani Sylvawani
Mahriani Sylvawani
FIFitri D. Ismida
Fitri D. Ismida
RARichard Y. Akele
Richard Y. Akele
Psoriasis vulgaris is a significant health problem and up to 30% of the patients are most likely to develop psoriatic arthritis. Secukinumab, an interleukin-17A (IL-17A) inhibitor, is used to treat patients with moderate-to-severe plaques associated with psoriatic arthritis. The aim of this case report was to highlight the efficacy of secukinumab treatment in a patient with both psoriasis vulgaris and psoriatic arthritis focusing the how to balance the benefits and adverse effects. A 36-year-old female came to Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia with chief complaint of itchy and scaly red plaques almost all over the body. The patient also experienced pain in both knees, both ankle joints and index finger as well as thumb in the right hand in the last year. The patient was diagnosed with psoriasis vulgaris and psoriatic arthritis, then treated with phototherapy and 15 mg of oral methotrexate each week for four weeks. Due to no improvement of the initial treatment, the patient received emollient and secukinumab at a dose of 300 mg/week subcutaneously for five weeks. The lesions began to disappear and the joint pain began to relieve. Secukinumab therapy was continued with a dose of 300 mg/month for six months. However, after six months, the patient complained of acnes appeared on the face. Therefore, the maintenance dose of secukinumab was decreased to 150 mg/month. After the reduced maintenance therapy was given, the patient came back with no complained of acnes. The erythematous plaques on trunk, back, arms and legs have subsided, as well as the joint pain. This case highlights that in a moderate-to-severe psoriasis associated with psoriatic arthritis, secukinumab is highly effective. However, since the potential adverse effects, education and regular follow-up are needed to analyze the success of the treatment and to be able to manage the adverse effects.